Publications by authors named "Scott Bussom"

Claim this Profile
P
PHY906(KD018), an adjuvant based on a 1800-year-old Chinese medicine, enhanced the anti-tumor activity of Sorafenib by changing the tumor microenvironment.
Wing Lam, Zaoli Jiang, Fulan Guan, Xiu Huang, Rong Hu, Scott Bussom

Sci Rep· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancer.
Muhammad Wasif Saif, Jia Li, Lynne Lamb, Kristin Kaley, Kyle Elligers, Scott Bussom

Cancer Chemother Pharmacol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment.
Ena Wang, Scott Bussom, Jinguo Chen, Courtney Quinn, Davide Bedognetti

BMC Med Genomics· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of chemicals and their metabolites from PHY906, a Chinese medicine formulation, in the plasma of a patient treated with irinotecan and PHY906 using liquid chromatography/tandem mass spectrometry (LC/MS/MS).
Wei Zhang, Muhammad W Saif, Ginger E Dutschman, Xin Li, Wing Lam, Scott Bussom

J Chromatogr A· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity.
Wing Lam, Scott Bussom, Fulan Guan, Zaoli Jiang, Wei Zhang

Sci Transl Med· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methods and rationale for the early detection of pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
Scott Bussom, Muhammad Wasif Saif

JOP· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraductal papillary mucinous neoplasia (IPMN). Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
Scott Bussom, Muhammad Wasif Saif

JOP· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TREX1 acts in degrading damaged DNA from drug-treated tumor cells.
Chuan-Jen Wang, Wing Lam, Scott Bussom, Hua-Mei Chang, Yung-Chi Cheng

DNA Repair (Amst)· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of hypoxia on the expression of phosphoglycerate kinase and antitumor activity of troxacitabine and gemcitabine in non-small cell lung carcinoma.
Wing Lam, Scott Bussom, Yung-Chi Cheng

Mol Cancer Ther· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of hypoxic treatment on the expression of phosphoglycerate kinase and the cytotoxicity of troxacitabine and gemcitabine.
Wing Lam, Chung-Hang Leung, Scott Bussom, Yung-Chi Cheng

Mol Pharmacol· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-activity studies of phenanthroindolizidine alkaloids as potential antitumor agents.
Wenli Gao, Scott Bussom, Susan P Grill, Elizabeth A Gullen, You-Cai Hu

Bioorg Med Chem Lett· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis